Top Industry Leaders in the Syringomyelia Market
Latest Syringomyelia Companies Update:
Biogen Idec While primarily focused on Alzheimer's disease, Biogen's research on neurodegenerative diseases could have potential implications for syringomyelia, particularly regarding understanding disease mechanisms and developing new therapeutic targets.
Medtronic The company's expertise in neurostimulation devices could lead to future applications in syringomyelia treatment, potentially for managing pain or improving motor function.
Neuronetics and Cala Health are developing non-invasive neuromodulation therapies for neurological conditions. While not directly targeting syringomyelia, their advancements in this field could offer potential options for
List of Syringomyelia companies in the market
- Stryker
- Medtronic Plc
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Johnson & Johnson Private Limited
- CONMED Corporation
- Novartis AG
- Smith & Nephew PLC
- Zimmer Holdings Inc.
- TransEnterix, Inc.
- Becton, Dickinson and Company
- Aspen Surgical Products, Inc.
- Olympus Corp.
- Richard Wolf GmbH
- Siemens Ltd.
- STORZ MEDICAL AG